weltkarte mit standorten

LOCATIONS

We work on a global scale in many countries around the world.

> READ MORE

The Biosimilars Group, Partnerlogo Protagen
The Biosimilars Group Partnerlogo Celonic
The Biosimilars Group Partnerlogo ccdrd

POWER BY MULTIPLICITY

An alliance of 5 specialized partners, each with its solid core competence, form one unique team to develop your biosimilar.

> READ MORE

The Biosimilars Group - Facts & Figures

FACTS & FIGURES

We have a track record in biosimilars development.

> READ MORE

weltkarte mit standorten
Europakarte neue Standorte

LOCATIONS

We work on a global scale in many countries around the world.

LOCATIONS: Bulgaria, Brazil, China, Denmark, Germany, Hungary, India, Jordan, Norway, Poland, Romania, Russia, Serbia, Spain, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States of America.

Power by multiplicity

An alliance of 5 specialized partners, each with its solid core competence, form one unique team to develop your biosimilar.

The Biosimilars Group Partnerlogo Pharmalex
  • Global regulatory development strategies for biosimilars
  • Statistical experts to streamline your biosimilar program
  • All types of health authority submissions
  • Pharmacovigilance services
The Biosimilars Group, Partnerlogo Protagen Protein Services
  • In-house experience with more than 30 originator proteins
  • Quality target definition and monitoring of Reference Molecule
  • Quality driven biosimilar development
  • Demonstration of biosimilarity
  • Stability and release testing
The Biosimilars Group Partnerlogo Celonic
  • Development of high titer production cell lines
  • Master / Working Cell Bank generation
  • Upstream and downstream process development
  • GMP production and analytics for clinical and market supply
The Biosimilars Group Partnerlogo ccdrd
  • Pioneering the field of biosimilars
  • Full service for phase 1-4 studies from protocol to report
  • Pharmacokinetic trials in healthy subjects and patients
  • Immunogenicity and therapeutic equivalence trials
  • Broad therapeutic spectrum

FACTS & FIGURES

Track record in biosimilars development

  • 1,100+ highly qualified experts in the group
  • 14 years of experience with biosimilars development
  • 300+ successful biosimilars projects across all functions
  • Working for customers worldwide from 35 countries on 4 continents
  • Regular successful submissions at EMA and FDA
  • Working for customers worldwide

solutions tailored to your specific requirements

The Biosimilars Group is covering all aspects of biosimilars development from candidate identification to marketed product.